In this issue:
FUS subthalamotomy for PD
Skin α-synuclein aggregation seeding activity as a novel biomarker for PD
SCD inhibitor prevents multiple PD phenotypes in α-synuclein mice
Nilotinib ineffective in moderately advanced PD
Orthostatic hypotension enhances cognitive effects of rivastigmine in PD dementia
Pioglitazone and statins lower PD incidence in diabetics
Progression of sleep disturbances in PD
Hospitalisation and mortality risk with COVID-19 in PD/parkinsonism
H. pylori eradication does not improve PD outcomes
Glycopyrrolate improves disability from sialorrhea in PD
Please login below to download this issue (PDF)